Health Condition 1: L508- Other urticaria
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Haritha Prasanth
Eligibility
Inclusion criteria
Inclusion criteria: CASES- 1. Clinically diagnosed patients with chronic spontaneous urticaria CONTROLS-1. Healthy individuals volunteering to participate in the study
Exclusion criteria
Exclusion criteria: CASES- 1. Patients exposed to treatment with antifungals and proton pump inhibitors one month before sample collection 2. Patients with active fever or gastrointestinal infections 3. Patients with history of GI surgeries 4. Patients with immunodeficiency disorders, auto-inflammatory syndromes, urticarial vasculitis, severe infections 5. Patients treated with systemic corticosteroids, immunomodulators 1 month before sample collection CONTROLS- 1. Individuals with personal history of urticaria, atopic dermatitis, allergic rhinitis, conjunctivitis, asthma, anaphylaxis 2. Individuals with other dermatological diseases, GI infection or history of GI surgeries, those diagnosed with irritable bowel syndrome, inflammatory bowel disease and any other autoimmune diseases 3. Use of systemic antifungals, proton pump inhibitors, systemic steroids, immunomodulators one month before sample collection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fungal gut microbiome in patients with chronic spontaneous urticaria and healthy controlsTimepoint: at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sebastian Criton
Amala Institute of Medical Sciences
Outcome results
None listed